Latest News & Features
Big Pharma
Pharmaceutical company Impax Laboratories engaged in illegal pay-for-delay settlements to stop a generic version of one of its medications from entering the market, the US Federal Trade Commission has ruled. 1 April 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, March 28, overturned a district court decision and handed a victory to pharmaceutical companies Endo and Mallinckrodt. 29 March 2019
Big Pharma
The UK Supreme Court’s decision in Actavis v Eli Lilly confirms that a multi-factorial judgement should be used to determine whether an invention is obvious or not, lawyers have told WIPR. 28 March 2019
Biotechnology
Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical. 28 March 2019
Big Pharma
The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step. 27 March 2019
Americas
Stanford University has accused genetic testing company Natera of infringing two patents that cover a non-invasive method of testing if transplanted organs are being rejected. 27 March 2019
Americas
Pharmaceutical company GSK has taken a Chinese company to court over its alleged “deliberate and unlawful campaign” to copy GSK’s trademarks. 26 March 2019
Americas
Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion. 26 March 2019
Big Pharma
The Court of Justice of the European Union’s recent refusal to provide further guidance on the full scope of Neurim in a case involving supplementary protection certificates last week has left some big questions unanswered. 25 March 2019
Biotechnology
A “biotech boom” is underway in the UK, according to a new report from UK investment management firm Downing. 25 March 2019